In order to find evidence of prognosis and of presymptomatic manifestation of congestive cardiomyopathy (COCM) in fifty-eight patients, the extent of morphological changes of endomyocardial catheter biopsy (EMCB), clinical and haemodynamic data were correlated to the clinical course. In addition, clinical, haemodynamic, angiographic, morphological and His-bundle electrographic studies were performed in patients with left bundle branch block (LBBB), normal left ventricular end-diastolic volume, and normal coronary arteries (n = 43).
Introduction
The clinical course of patients with congestive cardiomyopathy can vary considerably, i.e. it can be fast or slow or may even show transient remission 1975; Oakley, 1974; Harvey, 1970, 1974) . The diagnosis of COCM is mostly made in an advanced stage of the disease, as the presymptomatic manifestation of COCM is unclear. Therefore, following previous studies (Kuhn et al., 1974a (Kuhn et al., , 1975 Loogen and Kuhn, 1977; Breithardt et al., 1978) endomyocardial catheter biopsy (EMCB) was used in an attempt to get more information on prognosis of COCM. Clinical and haemodynamic data as well as biopsy results were correlated to the clinical course of the patients.
Former studies in a small number of patients gave some evidence for presymptomatic manifestation of COCM in patients with complete left bundle branch block (LBBB) . Now in a larger group of patients with LBBB of unknown aetiology, different investigations were performed, including haemodynamic and angiographic measurements, EMCB, His-bundle-electrography (His-BE) and estimation of minimal cardiac transit times (MTT) in order to find evidence for subsequent COCM.
Patients and methods
Fifty-eight patients with COCM (Goodwin and Oakley, 1972; Kuhn et al., 1973 , in whom EMCB could be performed, were studied. Biopsies were taken from the right ventricle, the right and left heart were catheterized, left ventricular cin6 angiogram, coronary arteriography, chest X-ray, ECG, phonocardiogram, apexcardiogram, external carotid pulse tracing and laboratory tests were carried out. Left ventricular cin6 angiograms, left ventricular end-diastolic volume (LVEDV) and left ventricular end-systolic volume (LVESV) were estimated from mono-planes using the area length method. From these data, indices were derived yielding LVEDVI . Generally one or three specimens were taken for both light-and electronmicroscopic examination (Kuhn et al., 1975 Haerten et al., 1976) . MTT were measured using ll3mIn before and at the end of ergometric work (Vyska et al., 1975; Losse and Loogen, 1978) .
The following definitions were used: (1) Duration of illness is the interval from the onset of symptoms to the date of myocardial biopsy. (2) Follow-up period is the interval from the date of myocardial biopsy to December 30, 1977. (3) Survival period is the interval from the date of biopsy to the death of the patient or, when still alive, to December 30, 1977. Statistical analysis was applied using the Wilcoxon test. Cumulative survival rates were calculated with the method of Cutter and Ederer (1958) .
Results
Mean age of all patients was 42 years, mean duration of illness before biopsy was 3 5 years (maximum 16 years, minimum 0-3 years) and mean survival period and follow-up period were 1-5 years and 2-6 years respectively. Figure 1 shows the cumulative survival rate of fifty-eight patients with COCM from the onset of illness to December 30, 1977 or the date of death. The 5-year survival rate was 65%, whereas the 10-year survival rate was only 30%.
The frequency and the extent of myocardial ultrastructural lesions varied. Myocardial hypertrophy, interstitial fibrosis and degenerative changes were the most frequently seen (Fig. 2 ). Patients were divided according to their morphological score (Table 2, Fig. 2 ). Group I (n= 30) consisted of those patients with <4 points, group II (n=28) of those with > 5 points. In both groups hypertrophy, interstitial fibrosis and myofibrillar changes were seen with near-equal frequency (Fig. 2) . However, alterations of mitochondria were observed in only three patients in group I and 21 in group II. Degenerative changes occurred in all patients of group II compared to eighteen in group I. Mortality was very high in group II (21 of 28, 75%/) and low in group I (nine of thirty, 30%/). Clinical and haemodynamic data were not significantly different in these two groups (Table 1) although CT-ratio and LVEDVI tended to be greater and EF tended to be lower in group II. The cumulative survival rate was lower at all intervals of follow-up in group II (Fig. 3 ). Survival rate after 4 years was 0%O in group I and 54%/ in group II. The prognostic significance of other parameters was tested by grouping the patients according to their final outcome regardless of the morphological score (Fig. 5) . Mean age and duration of illness were not significantly different when comparing those patients who died with those who survived. Survival period, follow-up period, morphological score, CTratio, LVEDVI and EF were significantly different. The scatter of individual data was highest in LVEDVI and EF. To test the relation between the extent of morphological changes and the duration of the illness, the morphological score was compared to the duration of illness and to its outcome (Fig. 4) . As can be seen, there was no positive correlation between the two. However, when focusing on those patients with a duration of illness < 2 years (n= 27), the survival could be predicted with a relatively high degree of accuracy by the morphological score. Only four patients with < 4 points died out of fourteen patients (age 37±10 years, duration of illness 12 +0-8 years, follow-up period 2-6+ 1-2 years), whereas ten of thirteen patients in the other group died (> 5 points). CT-ratio in these two groups was 0-569+0'065 and 0-602+t0059; EF was 408±t5'9 and 34-3±16-3%; EDVI was 136-9±31-9 and 180-1 64-2 ml/m2 respectively. Two-year cumulative mortality rate was 14% and 77%/ respectively. These differences were even more pronounced when focusing on those patients with a duration of illness of < 1 year. Only one of nine patients died with < 4 points, whereas seven of ten patients with > 5 points (Fig. 4) (Table 3 (Table 4) . Distribution of sex showed prevalence among men in COCM with LBBB (60%, total n=54) and among women in LBBB without COCM (53%4, total n=43).
The difference between mean age of COCM patients with and without LBBB was highly significant (Table 4) . In Fig. 6 MPAP at rest and at exercise is shown. As can be seen in twenty-six of forty-three patients an abnormal elevation of MPAP was found indicating latent left heart failure. Also the total of patients with LBBB (n=43) showed a significantly higher elevation of MPAP under exercise than was found in normal subjects. For the patients with abnormal elevated MPAP the diagnostic designation 'latent cardiomyopathy (LCM)' is proposed . Mean age of these patients with LCM (48 years) was significantly higher than in patients with LBBB and normal MPAP ('LBBB unknown group') (38 years), the scatter being again very great (Table  4) . LVEDP at rest, EDVI and EF were normal and not significantly different although EF was somewhat lower in patients with LCM. Aortic pressure showed a slight elevation (Fig. 7a and b) .
In twenty-one patients with LBBB and normal LVEDV right ventricular EMCB and both lightand electronmicroscopic examination of specimens were done (Fig. 8) . In nineteen patients abnormal findings were seen. In five patients even severe alterations of myocardial cells were present. Examples are shown in former work . For semi-quantitative evaluation the same morphological score was applied as in patients with COCM (Table  2) . Changes are summarized in Fig. 8 , including degenerative, mitochondrial and myofibrillar alterations, interstitial fibrosis and hypertrophy. Myofibrillar changes were rare in the 'LBBB unknown group' and more frequent in patients with LCM. Degenerative changes were more frequent in LCM. Abnormal findings observed in patients with LBBB without COCM were 90% by right ventricular biopsy; 72%, by His-BE; 60%, by measurement of MPAP; and 21% by measurement of MTT.
Discussion
The purpose of the present work was to correlate the degree of structural changes in COCM to the clinical course in order to get more information on prognosis which can vary considerably. In addition, various clinical, haemodynamic and angiographic data were examined for their prognostic significance. Studies on the possible presymptomatic stage of COCM were also performed.
Calculation of cumulative survival rate from the clinical onset of illness revealed a 10-year mortality rate of 70% (Fig. 1) . More differentiated information on prognosis was obtained by grouping the patients into those with slight changes (Q 4 points) and those with severe structural alterations (> 5 points) (Fig. 3) . Analysis of the morphological picture showed that mainly degenerative changes indicated a worse prognosis in COCM (Fig. 2) . Cumulative survival rate from the date of biopsy was then different, i.e. after 4 years it was 54% and 0% respectively. These results concerning the prognostic significance of pathological changes were recently confirmed by Bouhour et al. (1976) . Other measurements were not significantly different (Table 1) . However, grouping the patients regardless of morphological score in a different way (dead or alive) shows a prognostic significance not only of the morphological score but also of the cardiothoracic ratio, EF and LVEDV (Fig. 5) . Similar results have also been obtained by other authors (Goodwin and Oakley, 1972; Stapleton et al., 1974) . However, the great overlap of data reduces their prognostic usefulness for the individual patient. Best prognostic evaluation seems to be achieved by using all the data together, especially the results of biopsy, cardiothoracic ratio, EF and LVEDV.
EMCB alone seems to be of special prognostic and diagnostic value in patients with short duration of illness (Fig. 4) . In these cases (e.g. a sero-negative acute or subacute myocarditis), one cannot with certainty rule out the possibility of a good prognosis. The present data from patients with a duration of illness of 2 years have provided a new insight into the prognosis for these patients, and it seems even more pronounced for patients with a duration of illness of < one year (Fig. 4) . By use of the semiquantitative morphological score, a clear separation was made between those patients with a good prognosis (< 4 points, 2-year cumulative mortality rate 14%) and those with a very poor prognosis ( 5 points, 2-year cumulative mortality rate, 87%). Clinical data and haemodynamics of these two groups were different, showing the same tendencies as in the total of all patients.
The extent of pathological change was independent of the duration of illness (Fig. 4) (Kuhn et al., 1974 Loogen and Kuhn, 1977) (Blondeau, 1974 , Stapleton et al., 1970 there is a high incidence of complete LBBB in patients with COCM (nearly 40%, Table 4 ). (2) In former prospective and retrospective ECG studies in patients with LBBB and COCM, in no case a common LBBB developed (Kuhn et al., 1974a; Loogen and Kuhn 1977 (Vyska et al., 1975; Bonzel et al., 1976; ; ULsse and Loogen, in press); others included right ventricular morphological changes (total 90°%, severe changes 24%4), indicating a generalized myocardial disorder that apparently is not confined to the conduction system and left ventricle. For these patients (with or without LBBB) with normal LVEDV, normal inter-ventricular septum and normal posterior wall of left ventricle but impaired left ventricular function, mostly demonstrated by abnormal elevated LVEDP (i.e. MPAP), the term 'latent cardiomyopathy (LCM)' is proposed. The designation 'latent' is proposed because in most cases the LVEDP is elevated only on exercise and, because of the observations described above, the pre-existence of COCM in some of the patients may be presumed. The designation cardiomyopathy is based on the unclear aetiology and on the detection of abnormalities in right ventricle from biopsies (Fig. 8) . It may be supposed that LCM is an advanced stage of some patients with LBBB alone because the mean age of patients with LCM was significantly higher than that of patients with LBBB without LCM (38 and 48 years, range 28-55 and 31-61 years respectively). Also, EF was lower in these than in those with LBBB without LCM (Fig. 7) . A high percentage (72%/) of abnormal patients with LBBB was detected by His-BE (prolonged HV-time). The interpretation of prolonged HV interval in LBBB is controversial, but there is much evidence that this finding indicates a diffuse myocardial disorder which is not confined to the conduction system (Seipel, Breithardt and Kuhn, 1978) . Of significance was the occurrence of severe microscopic changes in patients with LBBB without LCM, i.e. without signs of impaired left ventricular function (Fig. 8) (five of fortythree patients with LBBB (24%), three of them being in the 'LBBB unknown group'); these changes are usually seen only in cases of advanced cardiac hypertrophy corresponding to various experimental and clinical stages of hypertrophied left ventricle (Ferrans et al., 1974 , Ferrans, 1978 , Kuhn, Pfitzer and Stoepel, 1974b . These may be the result of transient undetected arterial hypertension in some patients with LBBB (Schneider et al., 1976) or from former toxic influences, e.g. diphtheritic heart disease. These severe changes were also observed in a case of rate-dependent LBBB having a completely normal ECG in LBBB-free periods. In further considering the normal haemodynamic and angiographic findings, EMCB seems to be more sensitive for detecting myocardial disorder in these patients.
Taking all these observations on the possible early stage and prognosis of COCM into consideration, pre-symptomatic manifestation or pre-stage of COCM can be suspected in at least some patients with LBBB. These observations are supported by studies (Framingham heart study) reported recently by Schneider et al. (1976) who found that the onset of LBBB was associated in a high percentage with subsequent development of congestive heart failure. The occurrence of severe electronmicroscopic changes in patients with LBBB, indicating a bad prognosis in COCM, or the combination of both LCM and LBBB, possibly indicates subsequent COCM. Therefore, a new indication for performing EMCB emerges. Furthermore, it is possible that LBBB is only a predisposing factor for subsequent COCM, and only with additional 'specific' influences, such as arterial hypertension, virus infection, alcohol or pregnancy will COCM develop (Goodwin and Oakley, 1972; . It seems necessary that therapeutic advice by the physician to patients with LBBB considers these aspects especially in those patients with elevated MPAP at exercise and/or severe changes of heart muscle biopsy.
